Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05150236
Title 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION) (EVOLUTION)
Acronym ANZUP2001
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
St Vincents Hospital Darlinghurst New South Wales 2010 Australia Details
Calvary Mater Newcastle Newcastle New South Wales 2298 Australia Details
Royal Brisbane and Womens hospital Herston Queensland 4029 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field